Who funds cardiovascular disease research?
We count 255 funded cardiovascular disease projects, active between 2021 and 2035, from 7 funders. The most came from EU · ERC (62 projects), EU · MSCA (40 projects) and Wellcome (39 projects). The median award is $2.6M, across the 235 of 255 projects that list an amount.
- Funded projects
- 255
- Funders
- 7
- Median award
- $2.6M
- Open calls now
- 1
Top funders of cardiovascular disease research
| Funder | Projects | Share | Median award |
|---|---|---|---|
| EU · ERC | 62 | 24% | $1.9M |
| EU · MSCA | 40 | 16% | $261K |
| Wellcome | 39 | 15% | $1.4M |
| EU · Health | 34 | 13% | $7.7M |
| NIH · NHLBI | 19 | 7% | $3.7M |
| EU · EIC | 15 | 6% | $3.2M |
| NIH · NIA | 9 | 4% | $3.4M |
| EU · Digital, Industry and Space | 4 | 2% | $5.3M |
| NIH · NIMHD | 3 | 1% | $4.7M |
| NIH · NIDDK | 3 | 1% | $3.3M |
Projects whose title or summary mentions cardiovascular disease. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.
Open cardiovascular disease funding calls
1 open call mentions cardiovascular disease today.
-
Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
National Institutes of HealthUp to $500,000Deadline: March 10, 2027 ·
Funded cardiovascular disease projects
A sample, latest start first, at most three per program.
-
Jackson Heart Study (JHS) Coordinating Center: Task Area A - Core Study Operations
NIH · NHLBI · $3,791,131 · ends 2035
-
A big data approach to improving cardiovascular health of cancer survivors
Wellcome · £2,144,960 · ends 2034
-
Does menopause enhance Alzheimer’s Disease risk by exacerbating vascular dysfunction?
Wellcome · £1,686,636 · ends 2033
-
Understanding age-related immune dysfunction using human model systems
Wellcome · £2,607,935 · ends 2033
-
MWCCS UAB/UMMC Clinical Research Site
NIH · NHLBI · $3,315,025 · ends 2032
-
Alzheimer's Risk Intervention Trial with Estradiol (ARITE)
NIH · NIA · $5,945,498 · ends 2031
-
U19: Causes, Consequences, and Modifiers of Heterogeneity in Aging in a Naturalistic Nonhuman Primate Model
NIH · NIA · $7,287,697 · ends 2031
-
Establishing a technology platform to understand and harness the fundamentals of electrical-cellular interactions for future electro-medicine
UKRI · EPSRC · £1,686,167 · ends 2031
-
Peripheral Artery Disease Pain Assessment and Interventions: Vascular Interventions and Biopsychosocial Evaluation
NIH · NHLBI · $4,170,568 · ends 2030
-
Clean Air and Heat Relief: Evaluating Cardiovascular and Respiratory Health Outcomes Among Recipients of Oregon's Free AC and Air Filter Program
NIH · NIEHS · $3,203,867 · ends 2030
How we count
Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “cardiovascular”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.
Get matched with cardiovascular disease calls that fit your research
Build a free research profile and Lantern Grants scores every open call against your work, tracks your deadlines and reminds you before they pass.
Get matched free